The person responsible for entering the SCR call I.D. number into OORS is the individual who initiates or fields the single case report call and owns the resulting record in the FDA Adverse Event Reporting System workflow: typically the drug or device manufacturer's safety intake specialist or the responsible reporter (healthcare professional, consumer, or clinical site coordinator), depending on who received the call and which system generated the I.D. The exact owner is fixed by your organization's pharmacovigilance SOP and by whether the call arrived at a manufacturer's call center, a contract research organization, or FDA MedWatch.
This explainer goes one level deeper than most summaries. It separates what the acronyms mean, how an I.D. gets created and moved, where ownership transfers, and which failure modes cause the number to be missing or mismatched. It also flags a common public misunderstanding: SCR and OORS are not a simple form and database pair, and "responsible" is a role defined by process, not by job title.
What the acronyms actually denote
Two terms cause most of the confusion. SCR is used across industry documentation to mean a single case report: the individual report of an adverse event, product problem, or medication error tied to one patient and one product. It is the atomic unit of safety reporting. OORS is the Outbreak Operations and Response System (sometimes written as the Outbreak Operations Reporting System), a U.S. government data system used in public-health and emergency-response contexts.
A call I.D. is the unique identifier assigned when a call is logged, usually by a call-management or contact-center platform. It is generated at the moment of intake, before any clinical assessment happens. That timing matters: the I.D. exists before the case is validated, so the person who "enters" it may not be the person who ultimately owns the safety report.
Plain-language version: the call I.D. is a receipt number from the phone system, and the SCR is the medical file built around that receipt.
Because these acronyms are reused differently across agencies and vendors, the binding definition is always the one in your SOP and your system's data dictionary. Where a term is ambiguous, the controlled vocabulary wins, not common usage.
The mechanism: how an I.D. moves from phone to record
The transfer works in stages, and ownership changes at each one. Understanding the sequence explains why "who enters it" has more than one correct answer.
Stage one is call capture. A contact-center platform (for example, a telephony or CRM system) assigns a call I.D. at connection. The agent records caller identity, product, and event description. At this point the I.D. lives in the call system, not the safety database.
Stage two is triage. A safety intake specialist decides whether the call contains a reportable adverse event. If yes, an SCR is opened and the call I.D. is attached as a source reference. If no, the call is closed with a disposition code and no SCR exists.
Stage three is data entry. The intake specialist, or a dedicated case processor, keys the call I.D. into the safety database field designated for source identifiers. This is the literal act the question asks about.
Stage four is quality review. A reviewer checks that the I.D. matches the call log, that no digits were transposed, and that the record links to the correct patient and product.
Stage five is transmission. For expedited reports, the case is submitted to FDA through the electronic gateway, and the call I.D. travels as part of the source documentation. If the I.D. is wrong here, reconciliation becomes expensive.
The counterintuitive detail: in most mature workflows, no single human "owns" the I.D. entry end to end. The system generates it, the agent attaches it, the processor types it, and the reviewer verifies it. Accountability is distributed, which is exactly why errors survive.
Quantified context: where errors and delays concentrate
Numbers here are structural rather than study-derived, because published error rates for call I.D. transcription are not consistently reported across systems. Treat any specific percentage with suspicion unless it comes from your own audit data.
Call I.D.s are typically 8 to 20 alphanumeric characters. Human transcription error rates for short strings generally rise as length and character variety increase, especially when letters and numbers are mixed. A single transposed character breaks the link between call log and case file.
Entry timing is usually measured in hours, not days. Intake teams commonly target same-business-day case creation, with expedited serious reports due to FDA within 15 calendar days of initial receipt and 7 calendar days for certain follow-up information. The call I.D. must be entered before those clocks can be reliably audited.
Reconciliation cycles are commonly weekly or monthly. A mismatch found at reconciliation can cost hours of rework per case, and the cost scales with how many systems hold a copy of the identifier.
Red-flag warnings to watch for:
An SCR with a blank source-identifier field but a populated call log entry. A call I.D. entered with a leading zero stripped by a spreadsheet or import. Duplicate cases opened because the I.D. did not match and no one searched by it. I.D.s pasted from a different call during high-volume periods. Free-text entry of the I.D. where a validated picklist was intended.
Plain-language version: most I.D. failures are tiny typing or process slips, not deep system faults.
Timeline: the life of a call I.D.
The table below shows a typical sequence. Actual intervals depend on your SOP, staffing, and whether the case is serious and unexpected. It is a process model, not a regulatory schedule.
| Stage | Typical timing | Who acts | What happens to the I.D. |
|---|---|---|---|
| Call connection | Second 0 | Contact-center platform | I.D. generated automatically |
| Agent intake | Minutes 0-20 | Intake agent | I.D. attached to call notes |
| Triage decision | Within 1 business day | Safety specialist | I.D. linked to new SCR or closed |
| Case data entry | Within 1-2 business days | Case processor | I.D. keyed into source field |
| Quality review | Within 1-3 business days | Reviewer | I.D. verified against call log |
| Expedited submission | 7 or 15 calendar days | Regulatory affairs | I.D. travels in source documentation |
| Reconciliation | Weekly to monthly | PV operations | Mismatches corrected |
The key insight: the I.D. is created in seconds but verified days later. Every hour between creation and verification is a window where a mismatch can hide.
Edge cases and ownership transfers
Ownership is rarely as clean as "the intake specialist does it." Several scenarios shift responsibility.
When a call arrives at a contract research organization or vendor, the vendor's intake team enters the I.D. into the shared safety database, but the marketing-authorization holder remains legally accountable for the report's accuracy. Responsibility for entry and accountability for the record are different things.
When a healthcare professional reports directly to FDA MedWatch rather than to a manufacturer, no manufacturer call I.D. exists at intake. The manufacturer later receives the report and must attach its own internal identifier. The call I.D. concept may not apply at all.
When a clinical site coordinator reports a serious adverse event, the site's own tracking number may be entered alongside the sponsor's call I.D. Two identifiers in one field is a common source of mismatch.
When a consumer calls a general customer-service line instead of the safety line, the call I.D. is generated in the wrong system. The safety team must then re-key it or request a transfer, and the link is fragile.
When a system migration or vendor change occurs, legacy I.D.s may not map to new formats. Ownership of reconciliation temporarily shifts to data management.
When a call is abandoned or disconnected before intake completes, an I.D. may exist with no case. That orphan I.D. should be closed with a disposition, not left open.
Misconceptions worth correcting
Several assumptions cause teams to assign responsibility incorrectly.
Misconception one: the call I.D. is the case number. It is not. The call I.D. identifies the phone interaction; the case number identifies the safety record. They are related but distinct, and conflating them produces bad searches.
Misconception two: whoever answers the phone owns the entry. The agent captures the call, but a trained processor usually performs the database entry. Handing entry to untrained staff increases transcription errors.
Misconception three: the system fills the field automatically. Some integrations do, but many require manual keying, and manual entry is where digit transposition occurs.
Misconception four: a correct I.D. guarantees a correct case. A valid I.D. attached to the wrong patient record is worse than a blank field, because it looks complete.
Misconception five: OORS and the safety database are the same thing. They are separate systems with separate purposes, and a call I.D. may need to be entered in more than one place.
Professional caveat: in audits, reviewers care less about who typed the number and more about whether the trail from call log to submitted report is complete and traceable. A documented handoff beats an undocumented hero.
Practical actions: assigning and verifying responsibility
Use these steps to make ownership explicit and auditable. They are general process guidance, not regulatory advice for a specific product.
Define the owner in the SOP. State by role, not by name, who enters the call I.D. into the safety database and who verifies it. Name a backup.
Build the I.D. into the intake template. Make the source-identifier field mandatory before case closure, with format validation to catch stripped zeros and transposed characters.
Use picklists or barcode-style capture where possible. Free-text entry of identifiers is the single largest avoidable error source.
Set a verification threshold. Require a second-person check for serious, unexpected, or expedited cases before submission.
Run reconciliation on a fixed cadence. Compare call logs to open cases weekly and investigate any I.D. that appears in one system but not the other.
Track orphan I.D.s. Close abandoned calls with a disposition code so they do not masquerade as missing cases.
Train on the distinction between call I.D. and case number. Most confusion disappears once staff can state the difference in one sentence.
Threshold guidance, reconciled: entry should occur before any regulatory clock is audited, verification before submission, and reconciliation at least monthly. Where your SOP sets tighter intervals, the tighter interval governs.
Comparison: who enters the I.D. under each scenario
| Scenario | Who enters the call I.D. | Where it is entered | Main risk |
|---|---|---|---|
| Manufacturer call center | Intake specialist or case processor | Safety database source field | Digit transposition |
| Vendor or CRO intake | Vendor intake team | Shared safety database | Accountability gap with sponsor |
| Direct MedWatch report | Manufacturer safety staff | Internal case record | No manufacturer call I.D. exists |
| Clinical site report | Site coordinator or sponsor intake | Sponsor tracking system | Two identifiers in one field |
| Consumer to general line | Safety team after transfer | Re-keyed safety record | Wrong-system I.D. |
| System migration | Data management team | New system mapping | Legacy format mismatch |
The pattern is consistent: the entry owner is whoever controls the receiving system at the moment the case is created.
Limitations and what this cannot tell you
This explainer describes stable process mechanics. It does not provide your organization's SOP, system configuration, or regulatory obligations, which vary by product type, jurisdiction, and contract. Error rates and timing targets are structural illustrations, not measured benchmarks, and should be replaced with your own audit data.
Acronym usage is genuinely inconsistent across agencies and vendors. Confirm definitions against your controlled vocabulary before applying any rule here. Where a term is ambiguous, the data dictionary and SOP govern.
For any decision affecting regulatory submission, patient safety reporting, or legal exposure, consult your qualified pharmacovigilance, regulatory, or legal professionals. This article is general educational information, not a legal opinion, compliance determination, or treatment plan, and it does not promise any regulatory outcome.